Evidence map›Paper›PMID 36068079›Full record

ArticleBritish journal of pharmacology2023

Inhibition of transient receptor potential cation channel 6 promotes capillary arterialization during post-ischaemic blood flow recovery.

Takuro Numaga-Tomita, Tsukasa Shimauchi, Yuri Kato, Kazuhiro Nishiyama, Akiyuki Nishimura, Kosuke Sakata, Hiroyuki Inada, Satomi Kita, Takahiro Iwamoto, Junichi Nabekura and 3 more

Open access · hybridAbstract read
In one paragraph

Article in British journal of pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. TRPC6-Mediated ZnBiomolecules · 2025
    Article
  2. Pharmacological Activation of TRPC6 Channel Prevents Colitis Progression.International journal of molecular sciences · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Takuro Numaga-TomitaNational Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Aichi, Japan.
Tsukasa ShimauchiNational Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Aichi, Japan.
Yuri KatoGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.ORCID https://orcid.org/0000-0002-9426-911X
Kazuhiro NishiyamaGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Akiyuki NishimuraNational Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Aichi, Japan.
Kosuke SakataGraduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
Hiroyuki InadaNational Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Aichi, Japan.
Satomi KitaFaculty of Medicine, Fukuoka University, Fukuoka, Japan.
Takahiro IwamotoFaculty of Medicine, Fukuoka University, Fukuoka, Japan.
Junichi NabekuraNational Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Aichi, Japan.
Lutz BirnbaumerNIEHS, NIH, Research Triangle Park, North Carolina, USA.
Yasuo MoriGraduate School of Engineering, Kyoto University, Kyoto, Japan.
Motohiro NishidaNational Institute for Physiological Sciences (NIPS), National Institutes of Natural Sciences, Aichi, Japan.ORCID https://orcid.org/0000-0002-2587-5458
Kyushu University · JPNational Institutes of Natural Sciences · JPFukuoka University · JPKyoto University · JPResearch Triangle Park Foundation · USShinshu University · JP

Funding

Cooperative Study Program of National Institute for Physiological Sciences and Advanced Bioimaging Support (ABiS)Japan Agency for Medical Research and Development JP22ama121031Japan Society for the Promotion of Science 19H03383Japan Society for the Promotion of Science 19K07116Japan Society for the Promotion of Science 21H05269Japan Society for the Promotion of Science 22H02772Japan Society for the Promotion of Science 22H04814Japan Society for the Promotion of Science 22K06842JST, Core Research for Evolutional Science and Technology JPMJCR2024(20348438)National Research Foundation of Korea (NRF) funded by the Korean Government (MSIP) 2017K1A1A2004511Smoking Research Foundation
6 · The paper itself

Abstract

background and purposeCapillary arterialization, characterized by the coverage of pre-existing or nascent capillary vessels with vascular smooth muscle cells (VSMCs), is critical for the development of collateral arterioles to improve post-ischaemic blood flow. We previously demonstrated that the inhibition of transient receptor potential 6 subfamily C, member 6 (TRPC6) channels facilitate contractile differentiation of VSMCs under ischaemic stress. We here investigated whether TRPC6 inhibition promotes post-ischaemic blood flow recovery through capillary arterialization in vivo. EXPERIMENTAL APPROACH: Mice were subjected to hindlimb ischaemia by ligating left femoral artery. The recovery rate of peripheral blood flow was calculated by the ratio of ischaemic left leg to non-ischaemic right one. The number and diameter of blood vessels were analysed by immunohistochemistry. Expression and phosphorylation levels of TRPC6 proteins were determined by western blotting and immunohistochemistry. KEY

resultsAlthough the post-ischaemic blood flow recovery is reportedly dependent on endothelium-dependent relaxing factors, systemic TRPC6 deletion significantly promoted blood flow recovery under the condition that nitric oxide or prostacyclin production were inhibited, accompanying capillary arterialization. Cilostazol, a clinically approved drug for peripheral arterial disease, facilitates blood flow recovery by inactivating TRPC6 via phosphorylation at Thr69 in VSMCs. Furthermore, inhibition of TRPC6 channel activity by pyrazole-2 (Pyr2; BTP2; YM-58483) promoted post-ischaemic blood flow recovery in Apolipoprotein E-knockout mice. CONCLUSION AND IMPLICATIONS: Suppression of TRPC6 channel activity in VSMCs could be a new strategy for the improvement of post-ischaemic peripheral blood circulation.

Indexed as

Transient Receptor Potential ChannelsAnimalsIschemiaMiceMice, KnockoutMyocytes, Smooth MuscleTRPC6 Cation ChannelTRPC Cation ChannelsTransient Receptor Potential ChannelsTRPC6 Cation ChannelTRPC Cation Channelschannelperipheral arterial diseasephosphorylationtransient receptor potentialvascular smooth muscle cell

Identifiers

PMID36068079
PMCPMC10092707
OpenAlexW4295063301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.